Company record
ONESOURCE SPECIALTY PHARMA LIMITED
0 FDA warning letters since 2023 and 1 recall in the last 12 months.
Get an email the day FDA posts anything new about ONESOURCE SPECIALTY PHARMA LIMITED.
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Jul 15 | Class II | ONESOURCE SPECIALTY PHARMA LIMITED Drug |
Methohexital Sodium for Injection, USP 500 mg Multiple Dose Vial, Rx Only, Manufactured by: OneSource Specialty, Pharma Limited, Bengaluru - 561 203, India, Manufactured for: Avet Pharmaceuticals Inc., East Brunswick, NJ… Failed Impurities/Degradation Specifications |